| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.10B | +25.8% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | -25.9% |
| Gross margin | 26.2% | Net margin 7.0% |
| Revenue Q/Q | -80.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 73.8% |
| R&D | ¥0.01B | 10.7% |
| SG&A | ¥0.01B | 11.1% |
| Tax & other | ¥-0.00B | -0.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
浙矿股份 ・ 浙江力诺 ・ 博汇股份 ・ 酷特智能 ・ 康华生物 ・ 帝科股份 ・ 胜蓝股份 ・ 山水比德 ・ 捷安高科 ・ 首都在线 ・ 中船汉光 ・ 美瑞新材
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies